Simulations Plus, Inc. stock is up 10.35% since 30 days ago. The next earnings date is Jan 3, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 51.85% of the previous 26 December’s closed higher than November.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym; IPFsym; RENAsym; MITOsym.